MedTrace Logo

Comparison of Two Salpingectomy Techniques for Sterilization at the Time of Cesarean Delivery

NCT06273683 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2026-03-05

No results posted yet for this study

Summary

One in three women of reproductive age utilize tubal sterilization for contraception, and sterilization is often requested at time of cesarean delivery. Complete salpingectomy for the purpose of permanent sterilization at the time of cesarean birth is increasingly being performed worldwide.

A preferred complete salpingectomy technique for the purpose of sterilization at the time of cesarean delivery has not emerged in current practice. The objective is to compare short-term clinical outcomes and cost of salpingectomy using a hand-held bipolar energy instrument with those of traditional suture ligation. This retrospective cohort study will be conducted from 2017-2023 at a single tertiary care hospital. The investigators hypothesize that bipolar energy instrument use will not significantly improve clinical outcomes.

Conditions

  • Permanent Sterilization
  • Pregnancy Related

Interventions

OTHER

Hand-held bipolar energy instrument

A bipolar energy instrument is used for complete salpingectomy at the time of cesarean delivery.

OTHER

Traditional suture ligation

Traditional suture ligation technique is used for complete salpingectomy at the time of cesarean delivery.

Sponsors & Collaborators

  • Inova Health Care Services

    lead OTHER

Principal Investigators

  • Jean W Thermolice, MD · Inova Fairfax Medical Campus

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-11
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06273683 on ClinicalTrials.gov